Skip to main content
PLOS One logoLink to PLOS One
. 2020 Dec 4;15(12):e0243551. doi: 10.1371/journal.pone.0243551

Why women with breast cancer presented late to health care facility in North-west Ethiopia? A qualitative study

Aragaw Tesfaw 1,*, Wubet Alebachew 2, Mulu Tiruneh 1
Editor: Alvaro Galli3
PMCID: PMC7717512  PMID: 33275642

Abstract

Background

Although early diagnosis is a key determinant factor for breast cancer survival, delay in presentation and advanced stage diagnosis are common challenges in low and middle income countries including Ethiopia. Long patient delays in presentation to health facility and advanced stage diagnosis are common features in breast cancer care in Ethiopia but the reasons for patient delays are not well explored in the country. Therefore we aimed to explore the reasons for patient delay in seeking early medical care for breast cancer in North-west Ethiopia.

Methods

A qualitative study was conducted from November to December 2019 using in-depth interviews from newly diagnosed breast cancer patients in the two comprehensive specialized hospitals in North West Ethiopia. Verbal informed consent was taken from each participant before interviews. A thematic content analysis was performed using Open Code software version 4.02.

Results

Lack of knowledge and awareness about breast cancer, cultural and religious beliefs, economic hardships, lack of health care and transportation access, fear of surgical procedures and lack of trusts on medical care were the major reasons for late presentation of breast cancer identified from the patient’s narratives.

Conclusions

The reasons for late presentation of patients to seek early medical care for breast cancer had multidimensional nature in Northwest Ethiopia. Health education and promotion programs about breast cancer should be designed to increase public awareness to facilitate early detection of cases before advancement on the existing health care delivery system.

Background

Breast cancer is a group of diseases which results from uncontrolled growth and changes on breast tissue typically resulting in a lump or mass. It is the 2nd leading cause of cancer among females worldwide and a growing public health burden in low-resource settings [1, 2]. Based on the GLOBOCAN estimates around 2.1 million female breast cancer cases were diagnosed in 2018, accounting for almost 1 in 4 cancer cases among women [3]. It is the most prevalent cancer in African women, although its incidence is lower compared to high-income countries [4]. Approximately 1 in 8 women (13%) will be diagnosed with invasive breast cancer in their lifetime and 1 in 39 women (3%) will die from breast cancer [1].

As of World Health Organization (WHO) 2018 cancer country profile report, breast cancer is the leading cancer in Ethiopia with the highest age standardized mortality rate of 22.9 per 100,000 population [5]. Similarly according to the Addis Ababa population-based cancer registry report, breast cancer becomes the most frequently diagnosed malignant tumour accounting 33% of cancer cases in women and it is the commonest cancer in four of the six Ethiopian regions. The Estimated national Age Standardized Incidence rate for women was about 43 per 100,000 population [6].

As evidence shows an important determinant factor for breast cancer survival is the degree to which cancers are detected at early stages while advanced stage and large tumor size at diagnosis are associated with decreased survival and worse clinical outcomes [7, 8]. Localized disease have higher five year survival (99%) than metastasized or advanced stage cancer cases (26%) [9]. Similarly patients diagnosed at early stage of breast cancer showed better survival than patients with late stage in Ethiopia [10].

Studies showed that breast cancer is often diagnosed at an early stage and patients have good prognosis in developed countries. However, it is more often diagnosed at advanced stage and patients have low survival rates in developing countries [11]. Nearly three fourth (72.5%) of breast cancer patients diagnosed at advanced stage in Ethiopia [12].

An evidence from systematic review showed that patient delays in seeking early medical care for breast cancer is a major contributor for advanced stage diagnosis of breast cancer among African women [13]. Other studies also reported that patient delays in diagnosis affect cancer stage at diagnosis even though their characteristics is vary in particular countries [1416]. The way in which individuals understand and perceived their initial breast symptoms had shown to influence early medical seeking behavior due to their misunderstandings about the first clinical symptoms of the disease [17]. Patients who had painful breast wound were more likely to be presented early as compared with patients who had painless lumps [12, 14].

Lack of knowledge and awareness about breast cancer is found to be a contributing factor for late presentation to breast cancer care in most sub-Saharan African countries [13, 18].

The Breast Health Global Initiative (BHGI) recommends on to increase public awareness about risk factors, initial symptoms and early detection methods of breast cancer as well as providing accessible and effective diagnosis services for down staging breast cancer [19]. However there are still very few initiatives in developing countries to address the issue [20]. In Ethiopia, women’s knowledge about risk factors for breast cancer is low [21].

Breast cancer incidence is rising and becoming a major public health problem in Ethiopia which poses a substantial threat in the country with limited oncology centers [22, 23]. A large proportion of breast cancer patients in Ethiopia present for medical care too late, or not at all, resulting in high mortality [24]. The overall breast cancer screening practice is very low in the country (9%) [25] only few breast cancer patients sought medical advice within the first year (average time to presentation to health care facility of 1.5 years from their initial symptom recognition) [26]. Knowledge about breast cancer early detection methods (breast self-examination and clinical breast examination) is low in the country [27] only less than half (32.5%) of women practiced breast self-examination [28]. In addition women’s knowledge about risk factors for breast cancer is low [21]. About 73% of the patients had patient delays s of >90 days with a median presentation delay of 4 month and this patient presentation delay more than three month is associated to advanced stage of the disease [12]. Patient related barriers were one of key reasons for early diagnosis of breast cancer in south and southwestern Ethiopia [29].

Although Ethiopia has been developed the National Cancer Control Plan in 2015 for improving early diagnosis of cancer, and efforts are made, more than two-thirds of breast cancer cases are diagnosed at advanced stages of the disease and need palliative care [30]. There is only one radiotherapy center (Addis Ababa, Tikur Anbesa Hospital) in the country. Although some studies are done at the center and southwestern part of the country, little is known about the reasons for late presentation in North western part of the country. Therefore exploring the major reasons for women for delay in seeking medical care immediately when they saw breast cancer initial symptoms is crucial for designing prevention strategies at local and national level.

Clinical implication of the study

This study answered the question of why women with breast cancer presented late to health care facility in North West Ethiopia which is crucial particularly for health care providers and policy makers to develop specific health education and promotion interventions to promote early detection of cases before advancement at each level of health care delivery system in the country. The result will also insight health care providers to encourage women to regularly check their breast, to come for clinical check-ups and they will do clinical breast examination for all women coming to health care facility for other medical visits like anti-natal care, post-natal care follow ups, family planning purposes.

Methods

Study area and approach

A qualitative study using phenomenological approach was used to explore the reasons for late presentation of women for breast cancer care. We used these method since it is important to study “lived experiences of individuals about a certain phenomenon” in this case, the experience of breast cancer patients with their initial symptoms, their reasons for delay for seeking medical visit [31]. The study was conducted from November to December 2019 in two comprehensive specialized teaching hospitals located in the North-western Ethiopia (University of Gondar and Felege Hiwot Specialized hospitals). The hospitals are used as the only oncology referral centers for all cancer cases including breast cancer in the Amhara Regional State, Ethiopia. Felege Hiwot hospital is found in Bahirdar city 565 km far from Addis Ababa (the capital city of Ethiopia) while University of Gondar specialized hospital is a comprehensive specialized and teaching hospital found 724.7 km far from the capital city of Ethiopia (Addis Ababa). The hospitals play an important role in teaching medical and other health science students in different streams and specialities. The hospitals currently provide diagnostic, surgical and chemotherapy treatment service for cancer patients including breast cancer.

Participants of the in-depth interview and recruitment procedures

A total of 14 In-depth Interviews (IDI) were conducted in the two oncology units. The participants in this study were newly diagnosed female breast cancer patients in the two specialized hospitals (University of Gondar and Felege Hiwot Specialized hospitals). The hospitals (above) were selected because they are the only oncology centers in the region and serve mostly rural populations and have experience with treatment services for breast cancer patients. The investigators communicated first the hospital director and the oncology staffs and provided description of the study. Participants were selected using purposeful sampling technique [32]. Women whose age greater than 18 years and who were diagnosed with breast cancer from November to December 2019 and treated at the two oncology clinics were included in the study. The sample size was determined based on theoretical saturation of data during the time of data collection [33].

Data collection procedure

Participants of the study were selected with the help of the oncology unit nurses. After we obtained informed consent to participate, an appropriate place and time for an interview was arranged by the oncology unit coordinators. Interviews were conducted face to face with participants in a private room at the oncology unit. Two public health professionals who had a Master of public health in health education and promotion collected the data with the assistance of two note takers. Interviewers were fluent in written and spoken Amharic and English language.

A semi-structured interview guide was used to conduct a face to face in-depth interview with breast cancer patients (see S1 File). The guide was developed thorough literature review. It was first developed in English and then translated to the local language (Amharic) to facilitate discussion with patients. The discussion was focused on reasons for late presentation (why women’s did not immediately visit health facility when they encountered any breast abnormalities or changes in their breast). The interview guides consisted of open-ended questions like what do you understand about breast cancer before? What did you feel when you notice changes in your breast? How long did you live with the signs or symptoms before you visit health facility? Interviewers also used probing questions which guided the patients during the interview to get further clarification of the responses of the participants. All of the interviews were audio-recorded. Field notes were taken during the in-depth interview to include keynotes of the participants and to use as a backup in case the video records are lost.

The in-depth interview was conducted on 14 newly diagnosed breast cancer patients who had self-reported delay of more than three month from their initial symptom recognition until their first health care visit. Six of the patients were from University of Gondar and eight were from Felege Hiwot specialized hospitals. Patients were newly diagnosed with breast cancer during data collection period and they were recruited from oncology unit at selected hospitals.

Participants were encouraged by different techniques like probing of the questions to talk more about all aspects of the reasons for their delay in presentation to health facility. Demographic and clinical data was collected through medical records and from the participants during the interview.

All interviews were audio-recorded after the verbal consent of the study participants. The interview was continued until a point of saturation of information was reached. Each interview had taken approximately 40–60 minutes with the average interview time of 46.67 minutes.

The transferability of the findings was ensured by collecting data on two oncology units which are used as referral centres for cancer patients in North West part of the country (Amhara Region). This helped to get women from different corners of the region with different socio-demographic and cultural background. The data collectors and investigators were met on a daily basis after data collection and debriefed on their daily interview findings.

To maintain the trust worthiness and validity of the findings, the investigators developed rapport with patients who were participated in the study. Credibility was maintained through participant checking during in-depth interview, and through feedback of findings at the end of the study from whom the data was taken. Keeping a diary with information about impressions was enhanced conformability. The dependability of data was maintained by taking depth of information until reaching data saturation point which reflects a sample needed for the study i.e. when repeated patterns become apparent in the patients' narrations.

Data analysis procedure

The qualitative data generated from in-depth interviews (audio recorded data) was transcribed verbatim by re-listening the tape recorder several times and reading the field notes line by line and translated from Amharic to English language. The transcripts were cross-checked for any mistakes by simultaneous reading of the transcripts and listening the audio-recorded voices. Transcripts and translations were cross-checked for accuracy and consistency by two independent persons. Verbatim transcripts were imported into Open code software version 4.02 for coding similar ideas together without compromising the central idea. The coding was done line-by-line by the principal investigator. First, repeated responses from each question was identified then similar responses were grouped into codes, similar codes were categorized and similar categories were grouped in two themes. Thematic content analysis were used to analyse the data. The most frequently said quotes of respondents were selected and presented in italics. Where necessary, translated English grammar in direct quotes was corrected from transcriptions to ease readability and where necessary, placed in the first person context, but the content remains unchanged. The investigators undertook the entire research process from patient selection to publication of the results.

Ethical consideration

An ethical clearance letter was obtained from a Research Ethics Committee of Debre Tabor University, College of health sciences (reference number: 782/2012 E.C. /CHS). The permission and agreement consent was obtained from the study hospitals prior to the study after a brief explanation of the purpose of the study through support letter. Informed verbal consent was obtained from all participants of in-depth interview after a brief explanation of the aim of study. Confidentiality of information and privacy of participants’ interview was respected. The participants were told that information they provide use only for the purpose of this study. The names of the participants did not included in the interview guide rather specific codes were used. At the end of each interview necessary advice and right information, concerning breast cancer was provided to patients.

Result

Socio-demographic and clinical characteristics of breast cancer patients

The table below describes the socio-demographic characteristics of breast cancer patients participated in the in depth interview. A total of 14 newly diagnosed breast cancer patients were participated on the in-depth interview. The age of patients were ranged from 27 to 68 years with the median age of patients at diagnosis was 43.5 years. The majority 9 (64.3%) of the patients were diagnosed at stage III. Majority 12(85.7%) of the patients have delay of more than six month from their initial visit (Table 1).

Table 1. Socio-demographic characteristics of breast cancer patients diagnosed at University of Gondar and Felege Hiwot Specialized hospitals North-west Ethiopia, 2019.

Characteristics Frequency Percentage
Age group
<40 6 42.8
≥40 8 57.2
Home residence
Rural 10 71.4
Urban 4 28.6
Educational status
Illiterate 5 35.7
primary education completed 4 28.6
secondary education completed 3 21.4
College and above completed 2 14.3
Religion
Orthodox 12 85.7
Muslim 2 14.3
Marital status
Married 11 78.6
Single 3 21.4
Occupational status
Farmer 7 50
Government employee 2 14.3
House wife 5 35.7
Stage of breast cancer
    Stage II 5 35.7
    Stage III 9 64.3
Time from to first visit (patient delay
<6 month 2 14.3
>6 month 12 85.7

Patient reasons for late presentation for breast cancer care in Northwest Ethiopia

Sociodemographic, cultural, religious, access to health facility and transportation related reasons were explored from the narrations of breast cancer patients for delay presentation to medical care. Themes and subthemes were emerged from the narrations of the participants regarding the reasons for late presentation in seeking medical care for breast cancer (see S2 File).

Lack of knowledge and awareness related reasons for late presentations to breast cancer care

As the in-depth interview participants narrated, one of the major reason for late presentation for breast cancer care was lack of knowledge and awareness about breast cancer risk factors, early symptoms, early detection methods and treatments. Almost all patients did not know about breast cancer before their diagnosis. As the participants mentioned they were not aware about initial breast cancer symptoms, risk factors of the disease and diagnostic methods consequently they could not recognize the early breast abnormalities and did not want to seek early medical care. As the participants explained, the community as well as their family members did not know about breast cancer risk factors, and early detection methods rather link such kind of problems with other medical problems. Almost all breast cancer patients participated in this study were associate their initial breast symptoms with other problems and some considered it as a simple and self-limited condition. The lack of knowledge and awareness about breast cancer combined with the different perception of patients and community contributed for their late presentation to health care services consequently, to be diagnosed at advanced stage of the disease.

“…I did not heard about breast cancer. I saw the changes on my breast while I was sleep once up one a time but I did not think that it will be this kind of disease…I knew a women ((my husband’s sister) who had similar problem with me but her was healed by itself. (A 64 years old patient)

“…I did not know it before and I did not heard the name itself. The society said me it is 'MITCH (a local name given for any breast swelling in which the community perceived as it is due to exposing of breast to sunlight)… no one educate me about breast cancer before. (A 58 year’s old patient said)

Initial symptom misinterpretation and poor practice of early detection methods

All participants explained as there initial symptom was painless swelling on their breast. As they described they were not worry about it at first notice but the swelling was gradually increase in size and started pain which alerts them to seek care. Most of them detect the abnormalities unintentionally during take-off their cloths or when taking shower. Most of the patents did not regularly practice self-breast examination even they do not know about practice of breast self-examination. All did not have history of clinical check-ups for their breast. All women did not have history of mammography check-ups.

“No, No. I did not have experience of checking my breast. I saw the swelling when I was washing my body at river…I did not do breast self-examination before. (A 27 years old patient)

“…ehhhh…I did not examine my breast. I saw the swelling by accident… I was not going to health facility for check-up of my breast. (A 42-year-old patient said)

The other important reason explained by breast cancer patients for delay in seeking care for breast cancer was their misunderstanding of early symptoms of the disease. Though nearly all women first noticed lumps, all did not sought medical advice early, most of them started to seek medical consultation after 6 months of initial symptom recognition. As they clarified changes in their symptoms mainly the pain and enlargement of the swelling driven them to seek medical advice. Most participants did not think the initial lump would be cancer. As the patients reflected most of them it as easy and self-limited condition. As they said they waited triggering factors like pain, wound, pus or discharge to go to health care facility. As a result they fail to visit medical care early unless such things become manifested.

“… first it was a very small swelling and it was painless so I was not consider it as it will be sever disease but the wound becomes burst and tried to produce discharges…emmm… if I knew about cancer, I will come early when I saw the swelling early in my breast. But I ignored the initial swelling…” (A 50-year-old patient said)

“…my problem last a long time. I felt a painless swelling on my breast just before 3 years but I stayed healthy and it was not have any pain. So I was not think that it could be serious and severe my family also did not think that it will be cancer, they told me as it is self-limited and held by itself…” (A 38 year’s old patient said)

Access to health care facility and transportation related problems

The patients had faced problems to access health facilities on time due to long distances and high costs of transportation. Majority (10 of the participants) of the participants were from rural residence and faced such difficulties when accessing medical care. As the participants reflected most of the rural women came late to health facility after the disease is advanced. As the patients said patients from rural or hard to reach areas are not usually visited by health extension worker as a result they could not get education about cancer and other health related issues. Because of these their knowledge about the disease is low.

“I am not educated. I lived in the rural area. . . .I am a farmer. My breast problem starts before two yearsThe road is not safe for transportation from my home to health center so most of the time we go through foot to get the nearby health center. (A 48 year’s old patient said)

Cultural and spiritual related reasons for late presentation to breast cancer care

As narrations from the participants indicted cultural and religious perceptions and thoughts had their own contributions for their late medical care seeking for breast cancer. As the participants described almost all patients delayed seeking medical care just because they were spent time by using traditional treatments and spiritual treatments options. Almost all of the patients were used holy water and herbal medications before they visited medical care. In addition most of the patients have a strong belief on use of herbal medications and spiritual treatment options for treating anybody swellings than the modern medical care. Some patients also perceived that cancer is a disease due to sin and they consider it as GOD’s penalty. As the patients narrated almost all women came to health facility when they lose hope after they tried all spiritual and herbal treatment options. Most patients came to health facility as a last option. As the participants described most patient’s believed cancer as a cultural diseases resulted from either due to sin of the individual or just by GODs punishment as a result they took herbal medication which prepared from green leafy vegetables, other plant roots and leaves by the herbalists in the community. Additionally the community perceived as if they go to health facility and get injection, the needle will make it to spread inside the body and kill the patient.

“I think this is the disease from GOD. ..I saw a small swelling on my right breast but gradually it increases and becomes large. When I follow it becomes grow then I fear and I was going to traditional healer and I applied herbal medication on it. But it does not improved me.” (A 29 year’s old patient)

“…when I saw the swelling in my breast, I became worried and I went to church for pray and took holy water for a long time. I came know to hospital since the discharge become offensive. I could not sit near to other people because of the smell of the wound”. (A 27 year’s old patient)

“…When I followed, the swelling becomes increase in size then I feared and I went to traditional healer and he applied herbal medication on it (KEBAW). But it does not improved me rather the swelling becomes burst”.” A 37 years old patient

Fear of surgical procedures and lack of trust on medical care

As the breast cancer patients explained most of them believed that cancer cannot be treated medically and they perceived as any type of cancers do not have any medical treatment rather they trust on use of herbal medications and spiritual options like pray and holy water. Because of these most of the patients first visit traditional healers and spiritual areas and finally they tried to visit health care facility as a last option while some others lose hope and prefer dying in their home. As the women’s explained in addition to lack of trust in medical care, they fear the medical procedures which will be done for patients. As they said there is also a strong perception in the community that if a women go to hospital, they think as her breast will be cut and she will be died. The other important point mentioned by the participants was the community believe that the women’s breast is surgically removed, they do not perceived that she will be survived. The other barrier mentioned by the patients was they perceived that once a women’s breast is removed, she could not give birth and she could not married. They think as the women lost her feminist character. As most of the women’s said as the community advised them as not to go to health facility rather they advised them to die without losing their breast. As they said the community perceived it as a dignity. Because of the above mentioned factors most women do not seek early medical care and usually presented at advanced stage of the disease.

“…No one of my family member allowed me to go to operation and to remove my breast …They do not trust medical care even they believed that you will be died if you go to hospital and operated. But thy mentioned the experience of some other patients who died after operation and some others who cured applying herbal medication” (A 36 years old patient)

“… I know two patents who were diagnosed with breast cancer and whose breast was removed but after some years they died so the community knows this issue and they did not have a hope on medical treatment. (A 32 years old patient)

“… I am very aged and my neighbours were advised me to not to undergo surgery for my breast rather they advised me to die without losing it.” (A 68 years old patient)

Economic hardships and lack of support

Economic problems and social support were mentioned as reasons for late presentation to breast cancer care. As the participants explained most patients did not have adequate money for transportation costs. Those individuals who have money will go to the nearby health facility early for medical check-ups and they will get early diagnosis and treatment but others will stay at home a long time to find money so that they could not seek early medical care at a health facility. As the patients described most of them faced difficulty of getting money for their medical care and transportation costs. Patients also described that they lost some of their time by collecting money for their expense so they wait until that money is collected. This contributed for their delay in visiting health facility early when they saw the changes in their breast. Most of the women also described as they did not have any family and social support.

“… No one support me economically and I did not have adequate income even to grow my children’s. As a result I could not come early to hospital. I lived with the swelling more than two years since I could not afford the cost for diagnosis and treatment. (A 45 years old patient).

“…. I am a farmer and our harvesting system is not satisfactory. We live just hand to mouth. I do not have any money for further treatment after now…. I have no any family who can support me. (A 42 years old patient)

Discussion

Early detection of breast cancer is an important determinant factor for improving prognosis and to decrease mortality form the disease however delays in diagnosis and treatment results incurable disease and low survival rates [10, 11]. Breast cancer patients mainly from developing countries usually present late to health care facilities due to a number of reasons and usually diagnosed at advanced stages [34]. In contrast most of the patients from high income countries presented early to medical care and breast cancer is detected at earlier stages which results lower mortality and high survival rates [35]. So exploration using qualitative approach is an appropriate for an in-depth understanding of opinions, thoughts and feelings of breast cancer patients, and obtaining more detail information on the reasons for their delay in seeking early medical care.

Different studies reported several patient related reasons for delay for seeking early medical for breast cancer care however each of the reasons varies across the regions depending on the awareness, perception, accessibility of health infrastructure and economic status of countries [13, 36]. In this study we tried to explore the reasons for late presentation of breast cancer patients in seeking early medical care. Our study explored socio-cultural, religious and economics related reasons as the major reasons for patient delay to seek care for breast cancer. Lack of knowledge and awareness about breast cancer risk factors, initial symptoms and early detection methods, belief in herbal and spiritual options and economic hardships, lack of access for transportation and health care facilities, and belief that cancer has not any medical treatment were the major reasons identified for late presentation of breast cancer patients.

Lack of knowledge and awareness about breast cancer is the most important and preceding reason for late presentation to breast cancer care in our study. This finding is in line with the findings from other studies in most developing countries which stated poor knowledge and awareness was a major contributor for very long delays at home before seeking early medical care in most breast cancer patients [13, 20]. This study found that a strong interplay between the perception and early medical care seeking for breast cancer care. The participant’s knowledge and perception about breast cancer symptoms and risk factors is very low. Patients consider themselves not susceptible to the disease, although some believe that the condition would have potentially serious consequences as a result they are less likely to seek early medical care for any changes on their breast. This finding is similar to findings from other studies conducted in southwest Ethiopia and Addis Ababa (capital city of Ethiopia) [29, 37].

Most patients believe that breast cancer is a disease due to GOD punishments as result of their misconduct of religious rules or due to their sin and they think that the disease did not have any medical treatment. This misconception might also be the result of very low awareness and a sense of not being vulnerable. The result is in line with other qualitative findings in Ethiopia and other African countries [29, 38, 39].

In our study, participants believed that breast cancer is a serious and deadly disease. As the narrations from the patients showed that breast cancer is the most feared disease in the community but knowledge about the risk factors, and medical treatment options is low rather high trust on religious and traditional treatment options. The result is consistent with the study conducted in Addis Ababa and other countries [13, 29, 37].

In this study, the accessibility to media and health education and promotion services about breast cancer is limited mainly to rural people. The women’s knowledge and practice about breast self- examination is very poor. Despite the misconceptions related to the cause of breast cancer and its screening, the pattern of early medical seeking behaviour is low. A number of socio-cultural and religious barriers were mentioned that influence early medical seeking behaviour which is similar to other study findings [40, 41].

A major important patient related reason for seeking early medical care for breast cancer was the low access to information about breast cancer mainly for the rural populations. This reason was explained by the patients as their long distance from health care facilities and inaccessible to Medias particularly for the rural people makes them to have low information about breast cancer. Lack of knowledge about the disease delays in the search for early medical care, even when patients have seen the early signs and symptoms of the disease, they do not want to go to health facility since they perceived as their symptoms will be self-limited and not as such serious disease. This finding is similar to studies in other Sub-Saharan African countries [11, 13].

The findings from our study showed that most breast cancer patient’s delay in seeking medical care since they wait until their sign and symptoms become worse. This is mainly related with traditional or religious practices, which are strongly practiced in most Ethiopia populations [42]. Most breast cancer patients prefer to use herbal medications and holy water before they go to health care facilities following this most patients presented to hospital after trying all of these cultural and religious treatment methods which makes them to lost their time and suffer very long delays and consequently presented at advanced stages. This finding is similar to findings from southwest Ethiopia [29].

Finding from this study revealed that patients’ fear of medical procedures including mastectomy contributed for their delay to seek early medical care for their breast problem. This is associated with the community’s perception and fear that if the women is undergo surgery, she will be died and could not give birth without breast. In addition it is not acceptable in some communities to have one breast so women’s fear of this social stigma and discrimination since they believe that if a women losses her breast, she cannot give birth. This finding is consistent with other qualitative studies conducted at the capital and southern Ethiopia [29, 37].

The other important reason mentioned for presentation delay was being far from health care facilities mainly for the rural community in which they faced difficulties to get health education other information’s from health care provider’s advice and education about cancer. Patients from rural areas describe as they suffer long delays in presentation to health facilities associated with long distance to cancer diagnostic centres and lack of information access. This is similar to findings from other studies in which being from rural areas are experienced long delays in presentation to health facilities compared with urban people [14, 17]. Most the rural people are far from health care facilities and lack of access to information through leaflets, newspapers and other media’s because of this they have low knowledge and awareness about the disease and usually do not want to go to health care facilities early unless the disease becomes sever and sever.

Patients explained that the other major reason contributed for their delay in seeking early medical care is the way they give meaning for their early breast signs and symptoms. Most patients relate their first breast symptoms with other medical conditions like breast feeding, use of contraceptives and other disorders. As a result they delay in visiting health facilities as early as possible. They usually visit health care facilities when the initial symptoms become painful and when it affects their daily lives. This demonstrates poor awareness and knowledge of patients regarding importance of these early warning signs and symptoms of breast cancer. It was also explained as that painless swellings were often considered not serious or self-limiting. Similarly in Egypt breast cancer patients who did not have pain were present at later stage than those having pain as the initial symptom [43].

Majority of women thought that breast cancer is caused by a sin (supernatural power). Most patients fear socio-cultural stigma and discrimination. This is similar to a study conducted among reproductive age women in Ethiopia [40].

Clearly, in our study lumps were the first noticeable signs of breast cancer typically recognized by patients. Almost all of the patients in this study noticed a lump at some point accidently and most participants also misinterpreted it at first, as nothing to be serious. In fact, most patients ignored their lump for several years by relating it with other benign medical conditions. Most patients noticed more lumps or changes in their breast (pain, itching), which triggered them to seek advice, from herbalist, clinic, or other religious means. However in some breast cancer patients their cancer was discovered when they went to health facility for other medical problem. Several other studies have similarly found that lumps are the dominant symptom noticed by women with breast cancer and that most women find lumps as their primary symptom. Studies also indicate that women in low-resource areas delay seeking care longer than women in other parts of the world, with delays of a year or more from detection of symptom to seeking advice [12, 26, 29, 38]. Most women with breast cancer in African face significant delays in accessing care through overburdened health care systems and with limited resources; adding more than a year of delay from noticing a symptom to action increases the chances that their disease will progress significantly before care initiates [13, 18]. Participants’ awareness about the causes, risk, early symptoms, early detection methods, and treatment of breast cancer were poor and patients have a sense of hopelessness and uncertainty about the effectiveness of medical care rather applying spiritual actions (using holy water, pray) or seeking care from traditional healers were repeated responses from the in-depth interviews. The findings are similar to a study other parts of Ethiopia [12, 29, 37].

Strength and limitation of the study

Our study has certain strengths and limitations. To the best of the researcher knowledge, this is the first qualitative study conducted in North western part of Ethiopia to explore the reasons for late presentation of women to seek medical care for breast cancer. However, we only used in-depth interviews for data collection with only from patient’s perspective which might be better if it involves focus group discussions from health care providers and community key informants (HEW’s, religious leaders, and community health agents).

Conclusion

In conclusion, Lack of knowledge and awareness about breast cancer, initial symptom misinterpretation and poor practice of early detection methods, strong reliance on traditional and spiritual means of treatments, economic hardships, lack of health care access and transportation problems were the major reasons for late presentation of breast cancer patients. This shows the need to design intensive public campaigns to increase public awareness on breast cancer signs, symptoms, and treatment options and strengthening the capacity of the health care system is also essential to tackle the problem through early detection of cases and efforts to downstage the clinical presentation of breast cancer at local and national health care delivery levels.

Supporting information

S1 File. In-depth interview guide.

(PDF)

S2 File. Themes, categories and codes identified from in-depth interviews.

(PDF)

Acknowledgments

We would like to acknowledge the cooperation of each of the oncology unit staffs and medical directors of the study hospitals, data collectors and all participants in the interviews.

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.American Cancer Society. Breast Cancer Facts & Figures 2019–2020. Atlanta: American Cancer Society, Inc; 2019. [Google Scholar]
  • 2.Angahar LT. An Overview of Breast Cancer Epidemiology, Risk Factors, Pathophysiology, and Cancer Risks Reduction. MOJ Biology and Medicine. 2017;1(4). [Google Scholar]
  • 3.Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. 10.3322/caac.21492 [DOI] [PubMed] [Google Scholar]
  • 4.Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 Lyon, France: International Agency for Research on Cancer; 2013. [Google Scholar]
  • 5.World Health Organization: Cancer—a Growing Public Health Concern for Ethiopia 2015. [accessed september, 2019]. http://www.afrowhoint/news/cancer-growing-public-health-concern-ethiopia. [Google Scholar]
  • 6.Memirie ST, Habtemariam MK, Asefa M, Deressa BT, Abayneh G, Tsegaye B, et al. Estimates of Cancer Incidence in Ethiopia in 2015 Using Population-Based Registry Data. Journal of global oncology. 2018;4:1–11. 10.1200/JGO.17.00175 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Hiom SC. Diagnosing cancer earlier: reviewing the evidence for improving cancer survival. 112 Suppl 1: p. S1–5. Br J Cancer. 2015. 10.1038/bjc.2015.23 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Weiner CM, Mathewos A, Addissie A, Ayele W, Aynalem A, Wondemagegnehu T, et al. Characteristics and follow-up of metastatic breast cancer in Ethiopia: A cohort study of 573 women. Breast (Edinburgh, Scotland). 2018;42:23–30. 10.1016/j.breast.2018.08.095 [DOI] [PubMed] [Google Scholar]
  • 9.Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975–2012. http://seer.cancer.gov/csr/1975_2012/, based on November 2014 SEER data submission, posted to the SEER web site, April 2015. Bethesda, MD: National Cancer Institute, 2015. [Google Scholar]
  • 10.Kantelhardt EJ, Zerche P, Mathewos A, et al. Breast cancer survival in Ethiopia: A cohort study of 1,070 women. Int. J. Cancer 2014: 135; 702–709. 10.1002/ijc.28691 [DOI] [PubMed] [Google Scholar]
  • 11.Jedy-Agba E., et al. , Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis. The Lancet Global Health, 2016. 4(12): p. e923–e935. 10.1016/S2214-109X(16)30259-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Tesfaw A. Getachew S. Addissie A. et al. late stage diagnosis and associated factors among breast cancer patients in south and south west Ethiopia. a multicenter study. Clinical breast cancer. 2020. 10.1016/j.clbc.2020.08.011. [DOI] [PubMed] [Google Scholar]
  • 13.Akuoko C.P., et al. , Barriers to early presentation and diagnosis of breast cancer among African women living in sub-Saharan Africa. PLoS One, 2017. 12(2): p. e0171024 10.1371/journal.pone.0171024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Mousa S.M., et al. , Patterns of seeking medical care among Egyptian breast cancer patients: Relationship to late-stage presentation. The Breast, 2011. 20(6): p. 555–561. 10.1016/j.breast.2011.07.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Jedy-Agba E., et al. , Determinants of stage at diagnosis of breast cancer in Nigerian women: sociodemographic, breast cancer awareness, health care access and clinical factors. Cancer Causes Control, 2017. 28(7): p. 685–697. 10.1007/s10552-017-0894-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Ermiah et al. Diagnosis delay in Libyan female breast cancer. BMC Research Notes 2012; 5:452 10.1186/1756-0500-5-452 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Khan AM, Hanif S, Shahzad IMF, et al. Presentation delay in breast cancer patients and its association with socio-demographic factors in North Pakistan. Chinese Journal of Cancer Research 2015; 27(3). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Donkor A. Factors Contributing to Late Presentation of Breast Cancer in Africa: A Systematic Literature Review. Arch Med. 2015, 8:2. [Google Scholar]
  • 19.Yip HC, Smith AR, P Anderson OB et al. ,. The Breast Health Global Initiative Early Detection Panel. Guideline Implementation for Breast Healthcare in Low- and Middle-Income Countries. Cancer 2008; 113(8):2244–56. 10.1002/cncr.23842 [DOI] [PubMed] [Google Scholar]
  • 20.Unger-Saldana K. Challenges to the early diagnosis and treatment of breast cancer in developing countries. World J Clin Oncol. 2014;5(3):465–77. 10.5306/wjco.v5.i3.465 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Chaka B, Sayed AR, Goeieman B, Rayne S. A survey of knowledge and attitudes relating to cervical and breast cancer among women in Ethiopia. BMC public health. 2018;18(1):1072 10.1186/s12889-018-5958-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Memirie ST, Habtemariam MK, Asefa M, Deressa BT, Abayneh G, Tsegaye B, et al. Estimates of Cancer Incidence in Ethiopia in 2015 Using Population-Based Registry Data. Journal of global oncology. 2018;4:1–11. 10.1200/JGO.17.00175 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Deressa BT, Cihoric N, Badra EV, Tsikkinis A, Rauch D. Breast cancer care in northern Ethiopia—cross-sectional analysis. BMC cancer. 2019;19(1):393 10.1186/s12885-019-5612-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.De Ver Dye T, Bogale S, Hobden C, Tilahun Y, Hechter V, Deressa T, et al. A mixed-method assessment of beliefs and practice around breast cancer in Ethiopia: implications for public health programming and cancer control. Global public health. 2011;6(7):719–31. 10.1080/17441692.2010.510479 [DOI] [PubMed] [Google Scholar]
  • 25.Dibisa TM, Gelano TF, Negesa L, Hawareya TG, Abate D. Breast cancer screening practice and its associated factors among women in Kersa District, Eastern Ethiopia. The Pan African medical journal. 2019;33:144 10.11604/pamj.2019.33.144.18062 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Dye TD, Bogale S, Hobden C, Tilahun Y, Deressa T, Reeler A. Experience of initial symptoms of breast cancer and triggers for action in ethiopia. International journal of breast cancer. 2012;2012:908547 10.1155/2012/908547 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Abeje S, Seme A, Tibelt A. Factors associated with breast cancer screening awareness and practices of women in Addis Ababa, Ethiopia. BMC women's health. 2019;19(1):4 10.1186/s12905-018-0695-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Dagne AH, Ayele AD, Assefa EM. Assessment of breast self- examination practice and associated factors among female workers in Debre Tabor Town public health facilities, North West Ethiopia, 2018: Cross- sectional study. PloS one. 2019;14(8):e0221356 10.1371/journal.pone.0221356 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Getachew S, Tesfaw A, Kaba M, Wienke A, Taylor L, Kantelhardt EJ, et al. Perceived barriers to early diagnosis of breast Cancer in south and southwestern Ethiopia: a qualitative study. BMC women's health. 2020;20(1):38 10.1186/s12905-020-00909-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.FMOH. National Cancer Control Plan (2016–2020) Disease prevention and control directorate. Addis Ababa, Ethiopia: Federal Ministry of Health; 2015. [Google Scholar]
  • 31.Sibhat SG, Fenta TG, Sander B, Gebretekle GB. Health-related quality of life and its predictors among patients with breast cancer at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. Health and quality of life outcomes. 2019;17(1):165 10.1186/s12955-019-1239-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Palinkas LA, Horwitz SM, Green CA, et al. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Administration and policy. in mental health. 2015; 42(5):533–44. 10.1007/s10488-013-0528-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Trotter RT. Qualitative research sample design and sample size: resolving and unresolved issues and inferential imperatives. Preventive medicine. 2012; 55(5):398–400. 10.1016/j.ypmed.2012.07.003 [DOI] [PubMed] [Google Scholar]
  • 34.Espina C, McKenzie F, Isabel dos-Santos-Silva. Delayed presentation and diagnosis of breast cancer in African women: a systematic review: Annals of Epidemiology 27 (2017) 659 e671 10.1016/j.annepidem.2017.09.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Walters S, Maringe C, Butler J, et al. Breast cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK, 2000–2007: a population-based study. Br J Cancer. 2013;108:1195–1208. 10.1038/bjc.2013.6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Jassem J, Ozmen V, Bacanu F, et al. Delays in diagnosis and treatment of breast cancer: a multinational analysis, European Journal of Public Health 2013; 24(5): 761–767. 10.1093/eurpub/ckt131 [DOI] [PubMed] [Google Scholar]
  • 37.Gebremariam A, Addissie A, Worku A, Assefa M, Kantelhardt EJ, Jemal A. Perspectives of patients, family members, and health care providers on late diagnosis of breast cancer in Ethiopia: A qualitative study. PloS one. 2019;14(8):e0220769 10.1371/journal.pone.0220769 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Gebremariam A, Addissie A, Worku A, Assefa M, Pace LE, Kantelhardt EJ, et al. Time intervals experienced between first symptom recognition and pathologic diagnosis of breast cancer in Addis Ababa, Ethiopia: a cross-sectional study. BMJ open. 2019;9(11):e032228 10.1136/bmjopen-2019-032228 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Gakunga R, Kinyanjui A, Ali Z, Ochieng E, Gikaara N, Maluni F, et al. Identifying Barriers and Facilitators to Breast Cancer Early Detection and Subsequent Treatment Engagement in Kenya: A Qualitative Approach. The oncologist. 2019;24(12):1549–56. 10.1634/theoncologist.2019-0257 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Agide FD, Garmaroudi G, Sadeghi R, Shakibazadeh E, Yaseri M, Koricha ZB. How do reproductive age women perceive breast cancer screening in Ethiopia? A qualitative study. African health sciences. 2019;19(4):3009–17. 10.4314/ahs.v19i4.22 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Abeje S, Seme A, Tibelt A. Factors associated with breast cancer screening awareness and practices of women in Addis Ababa, Ethiopia. BMC women's health. 2019;19(1):4 10.1186/s12905-018-0695-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.De Ver Dye T. Bogale S. Hobden C. et al. A mixed-method assessment of beliefs and practice around breast cancer in Ethiopia: Implications for public health programming and cancer control, Global Public Health: An International Journal for Research, Policy and Practice 2011; 6(7): 719–731. 10.1080/17441692.2010.510479 [DOI] [PubMed] [Google Scholar]
  • 43.Stapleton MJ., Mullan BP. Dey S. et al. Patient-mediated factors predicting early and late stage presentation of breast cancer in Egypt, Psychooncology 2011; 20(5): 532–537. 10.1002/pon.1767 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Alvaro Galli

11 Sep 2020

PONE-D-20-18576

Why women with breast cancer presented late to health care facility in North-western Ethiopia? A qualitative study

PLOS ONE

Dear Dr. Tesfaw,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Oct 26 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Alvaro Galli

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2.  Please include a copy of the interview guide used in the study, in both the original language and English, as Supporting Information, or include a citation if it has been published previously."

3. Please amend your current ethics statement to address the following concerns: Please explain why written consent was not obtained, how you recorded/documented participant consent, and if the ethics committees/IRBs approved this consent procedure.

4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

5. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: No

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: It is a very good effort to describe the reasons underlying late presentation of breast cancer in North Western Ethiopia. Some genuine reasons have been presented as to why the breast cancer patients approach late to the health care facilities in that part of the country. However, the data of only 14 breast cancer patients spanned over the record of 1-2 months is not insufficient for any statistically significant information. I would suggest the authors to include as much number of patients as possible to report a significant data for such type of study.

Reviewer #2: Background:

1. This is a qualitative research design that examined the experiences of 14 women who delayed seeking medical care for breast cancer symptoms and were diagnosed with advanced breast cancer. I think the manuscript would be more interesting if the authors could expand the introduction section to include more information and background related to cultural factors that impact healthcare seeking of women experiencing breast cancer symptoms. Some of this literature could be compared to other cultures to give the reader more of an idea how the health care seeking behavior in Ethiopia is different or similar to other countries/cultures

2. Most up-to-date data sets should be used throughout the paper. 1st paragraph of the background should use most recent GLOBOCAN data (2018 Factsheet)-cite specific figures.

3. “Breast cancer is the most prevalent cancer in African women, although its incidence is lower compared to high-income countries”. Please provide evidence for this statement.

4. It would be good to have information regarding breast cancer’s incidence and mortality rates in Ethiopia and then compare it other developed countries to show the disproportionate burden of the disease.

5. “In Ethiopia, According to the Addis Ababa……...”, please change ‘’According’’ to according.

6. “Advanced stage and large tumour size at diagnosis are associated with decreased survival”. Please cite evidence for this statement.

7. …….. “A study conducted in 2011 among breast cancer patients in Ethiopia also revealed 47.8% of study participants were nothing know about breast cancer and never heard of the - 5 - disease at all [14]” Please make this claim clear to readers.

8. It would be very effective in addressing delay presentations if authors also compared developed western health care systems that have recently reported on presentations of breast cancer. It is also necessary to include information about the current breast cancer screening guidelines in Ethiopia. Because decreasing delay presentation and breast cancer mortality rate is also dependant on the availability of appropriate screening and timely treatment of breast cancer, some information about the current screening, diagnosis and treatment of breast cancer in Ethiopia would be very helpful here as well.

Methods

Study area and approach

The study setting is well described, however, there is no mention on the study design. Authors are advised to clearly state the study’s design, the rational for choosing the design whiles citing evidence to support it.

Participants of the in-depth interview and recruitment procedures

This section needs further description to aid in future transferability and replication of the study. The target population has been specified but the criteria for inclusion and exclusion are missing. Please add them. The participants recruitment procedure has not been described. Please provide detail description of how the study participants were recruited and enrolled into the study.

Data Collection Procedure

1. How were the participants sampled? Please include this.

2. Please what informed the selection of six and eight patients from the respective hospitals involved in the study

3. Please how did the authors determined patients with serious illness and communication difficulty. It will be very advisable for authors to clearly specify the eligibility criteria.

4. The interview guide was developed through literature review. Please describe the development process. How did the authors ascertained its reliability (thus, the ability to answer the study objective(s)? Were the guiding questions piloted? If yes, what was the outcome? Please include a type of semi-structured questions asked.

5. Please indicate the experience/expertise of researcher who conducted qualitative data collection.

6. There is no mention on how the participants were contacted. Who did the first contact? How were the interview appointments scheduled? Date, time, venue

7. Please calculate the average interview time.

8. What was the interview language?

9. How did the authors determined that the information has reached saturation?

10. Please describe how participants emotional reactions were addressed in the course of sharing their experiences.

11. It would be very helpful for the authors to provide detail on how data saturation was achieved since two individuals collected the data. Please indicate the number of interviews conducted by each interviewer.

12. Did each interviewer focused on one hospital or they conducted the interviews across the hospitals involved in the study.

13. Please describe how the anonymity and confidentiality were maintained in the data collection process.

14. Please clarify whether there was any change to the interview guide as the authors went along; often in qualitative methodologies, there is an iterative process where the questions are subsequently added or shaped based on the data that emerges prior to determining saturation was achieved.

15. How was the data managed?

Data Analysis procedure

1. Please who transcribed the data? Interviewers or different people?

2. Verbatim transcription in what language. Please describe the process of the translation into English and the background of the translators.

3. What analysis technique was employed for the data analysis. There is inconsistency on data analysis technique in the abstract and in this section. Please align. Authors need to describe specifically how they conduct analysis of this study.

16. Who analyzed the data? Please indicate the experience/expertise of researcher who conducted qualitative data analysis.

17. I suggest a reference to the open code software version 4.02. Please describe the analysis process sufficient detailed, so the readers have a clear understanding of how the analysis was carried out. The analysis is not clearly described i.e how text was categorized and developed to themes. Please, give some more details about the data analysis.

18. There is an obvious bias that is integrated into the qualitative analysis if interviewee and data analyst differ. The authors should explicitly explain whether and how this was addressed in their qualitative investigation, and speculate as to how this may have biased the results. They may also want to comment on whether both men and women were involved in the interpretation of findings as the research specifically focuses on women.

Ethics consideration

Please provide the ethical approval number

Rigor/trustworthiness

There is no mention on the study rigor and this is a major flaw of the study. How did the authors ensured the trustworthiness of this qualitative study?

Result

1. Under the data collection procedure, the authors claim they conducted in-depth interview on 14 newly diagnosed breast cancer patients who had self-reported delay of more than three month from their initial symptom recognition until their first health care visit. Now, in the results section, the authors report that majority of the patients have delay of more than six month from their initial visit. Please this is a confusing conflicting statement indicative of inconsistency and flaw. Please address this.

2. It would be easier for readers to appreciate the findings if authors specify the main themes and their sub-themes. Putting them in a table may be helpful. Table 2 is depicting the codes assigned to the recurring phrases from the participants’ narrations and not the main findings (main theme and sub-themes).

3. The result is described with a several quotations. Some of the quotations stands alone, so it would therefore facilitate for the reader if you could insert some short sentences in between the quotations to connect the paragraphs with each other.

4. In the "themes" section, there are quotes that do not demonstrate the claim/point made. Authors need to look closely to ensure appropriate quotes are used.

5. When there are more citations than authorial text, the analysis is usually incomplete, which I find in this paper. Why are only a few participants quotes included?

6. These results do not differ significantly from the general late presentation of breast cancer literature. They do, however, highlight some patient-related mediators, some of which may be difficult to understand without clarity around the early detection practices and why women would wait for over six months after symptom discovery and appraisal. The novel contributions of this study may be strengthened by providing further background around early detection and diagnostic practices in Ethiopia (e.g. lack of screening facilities, lack meaningful diagnostic facilities, lack of aid from social networks), or on specifically discussing in the discussion how poverty, stigma, fear and limited access to quality care have directly affected these women.

7. The author's results may be easier to interpret if they begin their results section in commenting on the demanding patient mediated factors that is highlighted in the results under the main themes and sub-themes. As it stands now, it seems the main themes had no sub-themes.

Discussion:

As a reader, I am somewhat surprised that all participants had similar experiences and that there are no specific experiences that may have differed between participants. This makes me wonder if the sample was not generalizable, or if these themes do truly apply to all women presenting late with breast cancer symptoms in Ethiopia. This should be discussed and explicitly addressed with the author's reflections

A clinical implications section would be helpful to help guide healthcare workers who are interacting with this population.

Language

Please look through your language and make improvements, for instance long sentences. Attention should also be paid to editing as there are some grammatical errors throughout the paper.

Thank you.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Shahid Mahmood Baig, Professor, Head of Health Biotechnology and Group Leader of Human Molecular Genetics at National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad 38000, PAKISTAN

Reviewer #2: Yes: ADWOA BEMAH Boamah Mensah

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Dec 4;15(12):e0243551. doi: 10.1371/journal.pone.0243551.r002

Author response to Decision Letter 0


30 Oct 2020

Dear, Editor,

Greetings!

Thank you very much for all the comments provided regarding our manuscript entitled Why women with breast cancer presented late to health care facility in North-western Ethiopia? A qualitative study which are fully accepted and included in the revised version. I have accordingly made necessary revisions on the paper following the comments provided from the reviewers and editor. I also attached the themes and subthemes as supplementary file 2 and in-depth interview guide as supplementary file 1 for the reviewers based on the request. For your kind consideration, please find a point by point response to the comments in the next page of this letter and a submitted new revised version of the manuscript.

All new changes have been highlighted in dark blue in the main document in order to facilitate review.

I hope that you will find the edits as per your expectation and I look forwards to hear from you

soon.

Yours Sincerely,

Aragaw Tesfaw (MPH, Epidemiology)

Lecturer, Department of Public health

College of health sciences, Debre Tabor University

Email: aragetesfa05@gmail.com

Phone: 251921743820

1. Point by point responses to editor comments

Author Reponses: corrected /edited based on the given editor comment

2. Point by point responses to the comments for reviewers

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: No

Author Reponses: we tried to modify the manuscript based on the findings.

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: N/A

Author Reponses: since the study is a qualitative study, statistical analysis is not applicable

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

Author Reponses: We put all relevant data within the paper and its Supporting Information files 1&2.

4. Is the manuscript presented in an intelligible fashion and written in Standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: No

Author Reponses: corrected/edited

Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

3. Reviewer #1: It is a very good effort to describe the reasons underlying late presentation of breast cancer in North Western Ethiopia. Some genuine reasons have been presented as to why the breast cancer patients approach late to the health care facilities in that part of the country. However, the data of only 14 breast cancer patients spanned over the record of 1-2 months is not insufficient for any statistically significant information. I would suggest the authors to include as much number of patients as possible to report a significant data for such type of study.

Author Reponses: We appreciate the reviewer comments but we determined the sample size based on the theoretical saturation point of data during data collection time when recurrent patterns become evident in the patients’ narrations or when no new data is emerged after the interviews of 14 participants. However, we planned to explore the barriers for breast cancer early diagnosis by including focus group discussions and in-depth interviews from health care providers, community health agents (locally called health development armies in Ethiopia), religious leaders, and from family members and communities perspective in another study. But in this study we just focused on patient’s perspective only, so the data collection was stopped when there was new data emerged from patient’s narrations (saturation of data).

4. Reviewer #2: Background:

1. This is a qualitative research design that examined the experiences of 14 women who delayed seeking medical care for breast cancer symptoms and were diagnosed with advanced breast cancer. I think the manuscript would be more interesting if the authors could expand the introduction section to include more information and background related to cultural factors that impact healthcare seeking of women experiencing breast cancer symptoms. Some of this literature could be compared to other cultures to give the reader more of an idea how the health care seeking behavior in Ethiopia is different or similar to other countries/cultures.

Author Reponses: corrected and edited based on the reviewer comments with the addition of some related literatures.

2. Most up-to-date data sets should be used throughout the paper. 1st paragraph of the background should use most recent GLOBOCAN data (2018 Factsheet)-cite specific figures.

Author Reponses: corrected/edited based on the reviewer comments

3. “Breast cancer is the most prevalent cancer in African women, although its incidence is lower compared to high-income countries”. Please provide evidence for this statement.

Author Reponses: corrected/ edited

5. It would be good to have information regarding breast cancer’s incidence and mortality rates in Ethiopia and then compare it other developed countries to show the disproportionate burden of the disease.

Author Reponses: corrected/ edited

5. “In Ethiopia, According to the Addis Ababa……...” please change ‘’According’’ to according.

Author Reponses: corrected/ edited

6“Advanced stage and large tumor size at diagnosis are associated with decreased survival”. Please cite evidence for this statement.

Author Reponses: corrected/ edited

6. …….. “A study conducted in 2011 among breast cancer patients in Ethiopia also revealed 47.8% of study participants were nothing know about breast cancer and never heard of the - 5 - disease at all [14]” Please make this claim clear to readers.

Author Reponses: corrected/ edited

8. It would be very effective in addressing delay presentations if authors also compared developed western health care systems that have recently reported on presentations of breast cancer. It is also necessary to include information about the current breast cancer screening guidelines in Ethiopia. Because decreasing delay presentation and breast cancer mortality rate is also dependent on the availability of appropriate screening and timely treatment of breast cancer, some information about the current screening, diagnosis and treatment of breast cancer in Ethiopia would be very helpful here as well.

Author Reponses: corrected/ edited

Methods

Study area and approach

the study setting is well described, however, there is no mention on the study design. Authors are advised to clearly state the study’s design, the rational for choosing the design whiles citing evidence to support it.

Author Reponses: corrected/ edited in the main document: our study design is a phenomenological study

Participants of the in-depth interview and recruitment procedures. This section needs further description to aid in future transferability and replication of the study. The target population has been specified but the criteria for inclusion and exclusion are missing. Please add them. The participant’s recruitment procedure has not been described. Please provide detail description of how the study participants were recruited and enrolled into the study.

Author Reponses: Corrected/ edited based on the comment

Data Collection Procedure

1. How were the participants sampled? Please include this.

Author Reponses: The participants in this study were newly diagnosed female breast cancer patients in the two specialized hospitals (University of Gondar and Felege Hiwot Specialized hospitals) and they were selected using purposeful sampling technique.

2. Please what informed the selection of six and eight patients from the respective hospitals involved in the study?

Author Reponses: Two data collectors with the assistance of two note takers were assigned in the two hospitals (one data collector and one note take in each hospitals). Then the sample size was determined based on the theoretical saturation of data in each of the study sites.

3. Please how the authors did determined patients with serious illness and communication difficulty. It will be very advisable for authors to clearly specify the eligibility criteria.

Author Reponses: corrected/ edited based on the document in the main document

4. The interview guide was developed through literature review. Please describe the development process. How the authors did ascertained its reliability (thus, the ability to answer the study objective(s)? Were the guiding questions piloted? If yes, what was the outcome? Please include a type of semi-structured questions asked.

Author Reponses: we used a semi-structure interview guide to collect data from the participants. The guide was developed by reading different literatures and it was submitted to experts in the field (clinical and surgical oncologists) and other health care providers to see judge content and face validity. It was initially prepared in English version but translated to the local language (Amharic).

5. Please indicate the experience/expertise of researcher who conducted qualitative data collection.

Author Reponses: Two public health professionals who had a Master of public health in health education and promotion collected the data with the assistance of two note takers (cancer trained clinical nurses). They are lecturers and have experience in qualitative research.

6. There is no mention on how the participants were contacted. Who did the first contact? How were the interview appointments scheduled? Date, time, venue

Author Reponses: Participants of the study were selected with the help of the oncology unit nurses. After we obtained informed consent to participate, an appropriate place and time for an interview was arranged by the oncology unit coordinators. Interviews were conducted face to face with participants in a private room at the oncology unit.

7. Please calculate the average interview time.

Author Reponses: Each interview had taken approximately 40-60 minutes with the average interview time of 46.67 minutes

8. What was the interview language?

Author Reponses: The local language which is called Amharic was used for in-depth interview

9. How did the authors determined that the information has reached saturation?

Author Reponses: the theoretical saturation point of data during data collection time was used to determine the sample size required in our study. This was defined when recurrent patterns become evident in the patients’ descriptions or when no new data is arose after the interviews.

10. Please describe how participant’s emotional reactions were addressed in the course of sharing their experiences.

Author Reponses: As the reviewer said when emotions raised during interviews from patients, the data collectors tried to reassure the patients and if necessary they link to oncologists and clinical psychologists for more reassurance. But it was not that much challenge in our study.

11. It would be very helpful for the authors to provide detail on how data saturation was achieved since two individuals collected the data. Please indicate the number of interviews conducted by each interviewer.

Author Reponses: One data collector was assigned with one note taker in each of the hospitals. Then each interviewer focused on only on their assigned hospital and interview the breast cancer patient’s reasons for their late presentation using the interview guide and they stopped when they could not get new information’s from patient narrations for the interviews.

12. did each interviewer focused on one hospital or they conducted the interviews across the hospitals involved in the study.

Author Reponses: Yes! Each interviewer were focused on one hospital which they were assigned and they continued interview until no new data is emerged from participants.

13. Please describe how the anonymity and confidentiality were maintained in the data collection process.

Author Reponses: Confidentiality of information and privacy of participants’ interview was respected. The participants were told that information they provide use only for the purpose of this study. The names of the participants did not included in the interview guide rather specific codes were used. All documents were kept private and confidential. All audio-recorded interviews were reviewed by the transcriber and the principal investigator only, and each participant was identified by specific code number, rather than by name.

14. Please clarify whether there was any change to the interview guide as the authors went along; often in qualitative methodologies, there is an iterative process where the questions are subsequently added or shaped based on the data that emerges prior to determining saturation was achieved.

Author Reponses: Yes! There was updates on the interview guide which was due to emerging of new ideas from the patients while interviewing. The interviewers used probing like questions to explore more in-depth information from the patients.

15. How was the data managed?

Author Reponses: All interviews were audio-recorded after the verbal consent of the study participants. Field notes were also taken during the in-depth interview to include keynotes of the participants and to use as a backup in case the video records are lose. There was debriefing each day after data collection with data collectors and investigators. Each collected data were also kept in password protected computer with the principal investigator.

Data Analysis procedure.

1. Please who transcribed the data? Interviewers or different people?

Author Reponses: data was transcribed by one another master of public health student and it was again cross-checked by two other independent persons!

2. Verbatim transcription in what language. Please describe the process of the translation into English and the background of the translators.

Author Reponses: Verbatim transcription was done first in local language/Amharic/ then translated to English. The translators were fluent in both English and Amharic language!

3. What analysis technique was employed for the data analysis? There is inconsistency on data analysis technique in the abstract and in this section. Please align. Authors need to describe specifically how they conduct analysis of this study.

Author Reponses: We used thematic content analysis approach to analyze the data in Open Code software.

16. Who analyzed the data? Please indicate the experience/expertise of researcher who conducted qualitative data analysis.

Author Reponses: the investigators were analyzed the data by consulting other experts in the field and who had qualitative research experience. One of the author has also experience in participating and doing qualitative researches.

17. I suggest a reference to the open code software version 4.02. Please describe the analysis process sufficient detailed, so the readers have a clear understanding of how the analysis was carried out. The analysis is not clearly described i.e. how text was categorized and developed to themes. Please, give some more details about the data analysis.

Author Reponses: Modifications are made based on the comment in the document

18. There is an obvious bias that is integrated into the qualitative analysis if interviewee and data analyst differ. The authors should explicitly explain whether and how this was addressed in their qualitative investigation, and speculate as to how this may have biased the results. They may also want to comment on whether both men and women were involved in the interpretation of findings as the research specifically focuses on women.

Author Reponses: yes! The interviewer and data analyzer were different but there was always debriefing and discussion after data collection daily between the data collectors and investigators. The data of this qualitative research were collected only female breast cancer patients.

Ethics consideration

Please provide the ethical approval number

Author Reponses: corrected/ edited

Rigor/trustworthiness

there is no mention on the study rigor and this is a major flaw of the study. How the authors did ensured the trustworthiness of this qualitative study?

Author Reponses: Descriptions were made in the main document as follows: The transferability of the findings was ensured by collecting data on two oncology units which are used as referral centers for cancer patients. This helped to get women from different corners of the region with different socio-demographic and cultural background. The data collectors and investigators were met on a daily basis after data collection and debriefed on their daily interview findings. To maintain the trust worthiness and validity of the findings, the investigators developed rapport with patients who were participated in the study. The dependability of data was maintained by taking depth of information until reaching data saturation point which reflects a sample needed for the study i.e. when repeated patterns become apparent in the patients' narrations.

Result

1. Under the data collection procedure, the authors claim they conducted in-depth interview on 14 newly diagnosed breast cancer patients who had self-reported delay of more than three month from their initial symptom recognition until their first health care visit. Now, in the results section, the authors report that majority of the patients have delay of more than six month from their initial visit. Please this is a confusing conflicting statement indicative of inconsistency and flaw. Please address this.

Author Reponses: Self-reported delay of more than three month from their initial symptom recognition until their first health care visit was our inclusion criteria to select participants but the majority had delay of more than six month so we included them to participate since our sampling technique was purposive focusing on which group of patients will give us more information on reasons for late presentation.

2. It would be easier for readers to appreciate the findings if authors specify the main themes and their sub-themes. Putting them in a table may be helpful. Table 2 is depicting the codes assigned to the recurring phrases from the participants’ narrations and not the main findings (main theme and sub-themes).

Author Reponses: corrected/ edited (See supplementary file_2)

3. The result is described with a several quotations. Some of the quotations stands alone, so it would therefore facilitate for the reader if you could insert some short sentences in between the quotations to connect the paragraphs with each other.

Author Reponses: Modifications were made based on the reviewer comments on the main document

4. In the "themes" section, there are quotes that do not demonstrate the claim/point made. Authors need to look closely to ensure appropriate quotes are used.

Author Reponses: corrected/ edited based on the comment

5. When there are more citations than authorial text, the analysis is usually incomplete, which I find in this paper. Why are only a few participants quotes included?

Author Reponses: corrected/ edited

6. These results do not differ significantly from the general late presentation of breast cancer literature. They do, however, highlight some patient-related mediators, some of which may be difficult to understand without clarity around the early detection practices and why women would wait for over six months after symptom discovery and appraisal. The novel contributions of this study may be strengthened by providing further background around early detection and diagnostic practices in Ethiopia (e.g. lack of screening facilities, lack meaningful diagnostic facilities, lack of aid from social networks), or on specifically discussing in the discussion how poverty, stigma, fear and limited access to quality care have directly affected these women.

Author Reponses: As we tried to mention in the background section, there are limited oncology centers in Ethiopia and cancer did not get focus in the country. In recent times some of referral and specialized hospitals start pathologic testing like FNC and biopsy and around six hospitals start oncology service for cancer patient’s surgery, chemotherapy. But there is only one radiotherapy center (Tikur Anbesa Hospital) in the country for more than 110 million population.

7. The author's results may be easier to interpret if they begin their results section in commenting on the demanding patient mediated factors that is highlighted in the results under the main themes and sub-themes. As it stands now, it seems the main themes had no sub-themes.

Author Reponses: Corrected/ edited based on the comment!

Discussion:

As a reader, I am somewhat surprised that all participants had similar experiences and that there are no specific experiences that may have differed between participants. This makes me wonder if the sample was not generalizable, or if these themes do truly apply to all women presenting late with breast cancer symptoms in Ethiopia. This should be discussed and explicitly addressed with the author's reflections.

Author Reponses: corrected/ edited

A clinical implications section would be helpful to help guide healthcare workers who are interacting with this population.

Author Reponses: We write the clinical implications of this study findings!

Language

Please look through your language and make improvements, for instance long sentences. Attention should also be paid to editing as there are some grammatical errors throughout the paper.

Thank you.

Author Reponses: modifications on the grammar were made based on the comments

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

7. Reviewer #1: Yes: Shahid Mahmood Baig, Professor, Head of Health Biotechnology and Group Leader of Human Molecular Genetics at National Institute for Biotechnology and Genetic Engineering (NIBGE), Faisalabad 38000, PAKISTAN

8. Reviewer #2: Yes: ADWOA BEMAH Boamah Mensah

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Alvaro Galli

24 Nov 2020

Why women with breast cancer presented late to health care facility in North-western Ethiopia? A qualitative study

PONE-D-20-18576R1

Dear Dr. Tesfaw,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Alvaro Galli

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have addressed all the comments adequately. The manuscript is recommended in its present form provided a very careful proof reading is done.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Shahid Mahmood Baig

Acceptance letter

Alvaro Galli

27 Nov 2020

PONE-D-20-18576R1

Why women with breast cancer presented late to health care facility in North-west Ethiopia?  A qualitative study

Dear Dr. Tesfaw:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Alvaro Galli

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. In-depth interview guide.

    (PDF)

    S2 File. Themes, categories and codes identified from in-depth interviews.

    (PDF)

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES